LaNova Medicines
Aggregated from S&P 500 earnings calls
Total Mentions
4
Companies
1
Sentiment
NEUTRAL 1
Mentions by Company
Merck & Co. Inc.Q3-2025
4×NEUTRAL
“Charge of $0.10 per share for milestone payment to LaNova for Technology Transfer for MK-2010”
“Charge of $300 million in the third quarter of 2025 related to a milestone payment to LaNova”